FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to dihydropyrimidin compounds of formula (I) or (Ia), as well as to pharmaceutical compositions based on them.
(I) or (Ia).
EFFECT: new compounds have been obtained that can be used in the treatment and prevention of HBV diseases.
4 cl, 4 tbl, 51 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2013 |
|
RU2655914C9 |
| DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2014 |
|
RU2678990C1 |
| PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATE COMPOUNDS THEREOF | 2014 |
|
RU2688193C1 |
| PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATE PRODUCTS THEREOF | 2014 |
|
RU2697707C1 |
| TRICYCLIC COMPOUNDS AND THEIR USE | 2016 |
|
RU2724100C2 |
| PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES | 2015 |
|
RU2709810C2 |
| PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
| NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITING ACTIVITY | 2019 |
|
RU2768755C1 |
| THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY | 2014 |
|
RU2703273C2 |
| URAT1 INHIBITORS | 2015 |
|
RU2721844C2 |
